Loading
Loading
Metabolic & Body Composition · 5mg + 5mg
Janoshik-tested · 10 vials per kit
Retatrutide + Cagrilintide is a research blend combining a triple GLP-1/GIP/glucagon receptor agonist with a long-acting amylin analog, studied for synergistic metabolic effects. Research has examined their combined potential for appetite suppression, enhanced satiety signalling, and improved glycemic and cardiometabolic markers via complementary receptor pathways.
Blended compound — purity note
Peptide blends are not tested for combined purity as a single compound. However, every component is sourced from the same supplier as our individual peptide products, all of which carry valid Janoshik Analytical COAs. Those certificates apply equally to the same peptides in this blend. View individual COAs →
≥98%
Purity
Lyophilised
Format
2–3 wks
Arrival
Don't want to wait 3 weeks?
Check local stock — weekday same/next-day delivery available.
Need to work out your dose?
Use our reconstitution calculator — syringe units in seconds.
Research Use Only — Disclaimer
This product is intended solely as a research chemical for laboratory and scientific study purposes only. It is not approved by the TGA or any regulatory body for human or animal consumption, therapeutic use, or clinical application. The information provided on this website is for educational purposes only. Handling must be limited to suitably qualified professionals operating within applicable laws and regulations. This product is not classified as a drug, food, cosmetic, or medicinal product and must not be used or labelled as such. By purchasing, you confirm you are a qualified research professional and accept full responsibility for compliance with all relevant laws in your jurisdiction.
Don't have supplies? Grab them while you're here.
